IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announced that it ...
Fierce Healthcare

ProCure Selects IBA One More Time as Supplier for a Proton Therapy System

Louvain-la-Neuve, Belgium--(BUSINESS WIRE)-- IBA (Ion Beam Applications S.A.) announced that it has signed a contract with Seattle Procure Management LLC for the installation of a proton therapy ...
Fierce Healthcare

IBA Signs Letter of Intent to Install First Proteus ONE™* Proton Beam System at Nice, France Proton Therapy Center

SAN DIEGO--(BUSINESS WIRE)-- The Centre Antoine-Lacassagne Cancer Center (CAL), in Nice, France, has signed a letter of intent with IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg ...
Finanznachrichten

IBA SA: Heidelberg University Hospital expands its particle therapy program with IBA's ProteusONE solution

Louvain-La-Neuve, Belgium, August 20, 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy ...
The Manila Times

IBA - TRANSPARENCY NOTIFICATION

IBA (Ion Beam Applications), the world leader in particle accelerator technology, announces that it has to issue a ...